Search - tctmd.com

Displaying 161 - 180 of 180

Sort: Relevancy | Date

Presentation TCTAP 2012

P2Y12 Receptor Inhibitors: Which Drug and for Whom?

Presenter: Cheol Whan Lee

April 26, 2012

News Daily News

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

April 25, 2012

News Daily News

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Caitlin E. Cox

March 06, 2012

News Daily News

Genetic Predictors of Early Stent Thrombosis Identified

L.A. McKeown

October 25, 2011

News Daily News

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

L.A. McKeown

September 20, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

Predictors of Serious Bleeding in ACS Patients from TRITON-TIMI Identified

June 09, 2011

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

L.A. McKeown

April 15, 2011

News Daily News

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

L.A. McKeown

March 29, 2011

News Daily News

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

L.A. McKeown

March 15, 2011

News Daily News

Platelet Assay May Help Predict Major Bleeding after PCI

L.A. McKeown

February 03, 2011

News Daily News

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

Caitlin E. Cox

January 25, 2011

CME

Aspirin for the Interventionalist: More Than Meets the Eye

CME

Everyday Antiplatelet Decisions: Making the Right Choices

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

Advertisement

P2Y12 Receptor Inhibitors: Which Drug and for Whom?

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Genetic Predictors of Early Stent Thrombosis Identified

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

ESC Congress 2011: Drugs, Devices Work Together

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Predictors of Serious Bleeding in ACS Patients from TRITON-TIMI Identified

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

Platelet Assay May Help Predict Major Bleeding after PCI

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

Aspirin for the Interventionalist: More Than Meets the Eye

Everyday Antiplatelet Decisions: Making the Right Choices

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content